|
US6822267B1
(en)
*
|
1997-08-20 |
2004-11-23 |
Advantest Corporation |
Signal transmission circuit, CMOS semiconductor device, and circuit board
|
|
EP1169031A1
(en)
*
|
1999-04-09 |
2002-01-09 |
British Biotech Pharmaceuticals Limited |
Antimicrobial agents
|
|
NZ517613A
(en)
*
|
1999-09-08 |
2004-01-30 |
Sloan Kettering Inst Cancer |
Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
|
|
EP1748046A3
(en)
*
|
1999-11-23 |
2007-08-22 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
|
PE20020354A1
(es)
|
2000-09-01 |
2002-06-12 |
Novartis Ag |
Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda)
|
|
EP1335898B1
(en)
|
2000-09-29 |
2005-11-23 |
TopoTarget UK Limited |
Carbamic acid compounds comprising an amide linkage as hdac inhibitors
|
|
GB0023983D0
(en)
|
2000-09-29 |
2000-11-15 |
Prolifix Ltd |
Therapeutic compounds
|
|
JP4975941B2
(ja)
|
2000-09-29 |
2012-07-11 |
トポターゲット ユーケー リミテッド |
（ｅ）−ｎ−ヒドロキシ−３−（３−スルファモイル−フェニル）アクリルアミド化合物及びその治療用途
|
|
US7842727B2
(en)
*
|
2001-03-27 |
2010-11-30 |
Errant Gene Therapeutics, Llc |
Histone deacetylase inhibitors
|
|
US7312247B2
(en)
*
|
2001-03-27 |
2007-12-25 |
Errant Gene Therapeutics, Llc |
Histone deacetylase inhibitors
|
|
US7314953B2
(en)
|
2001-03-27 |
2008-01-01 |
Errant Gene Therapeutics, Llc |
Treatment of lung cells with histone deacetylase inhibitors
|
|
US8026280B2
(en)
*
|
2001-03-27 |
2011-09-27 |
Errant Gene Therapeutics, Llc |
Histone deacetylase inhibitors
|
|
CA2465075A1
(en)
|
2001-06-14 |
2002-12-27 |
Sloan-Kettering Institute For Cancer Research |
Hdac9 polypeptides and polynucleotides and uses thereof
|
|
JP4238728B2
(ja)
|
2001-08-21 |
2009-03-18 |
アステラス製薬株式会社 |
ヒストンデアセチラーゼ阻害剤の医薬用途ならびにその抗腫瘍効果の評価方法
|
|
AU2002340253C1
(en)
|
2001-10-16 |
2011-03-31 |
Sloan-Kettering Institute For Cancer Research |
Treatment of neurodegenerative diseases and cancer of the brain
|
|
US7229963B2
(en)
|
2001-10-18 |
2007-06-12 |
United States of America as represented by the Secretary of the Department of of Health Services, National Institutes of Health |
Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
|
|
JP2005525345A
(ja)
*
|
2002-02-15 |
2005-08-25 |
スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ |
Ｔｒｘ媒介性疾患を処置する方法
|
|
US20050288227A1
(en)
*
|
2002-02-15 |
2005-12-29 |
Marks Paul A |
Use of thioredoxin measurements for diagnostics and treatments
|
|
US20040132825A1
(en)
*
|
2002-03-04 |
2004-07-08 |
Bacopoulos Nicholas G. |
Methods of treating cancer with HDAC inhibitors
|
|
US7148257B2
(en)
*
|
2002-03-04 |
2006-12-12 |
Merck Hdac Research, Llc |
Methods of treating mesothelioma with suberoylanilide hydroxamic acid
|
|
CN101259120B
(zh)
*
|
2002-03-04 |
2012-07-04 |
Hdac默克研究有限责任公司 |
辛二酰苯胺异羟肟酸或其可药用盐在制备诱导末期分化的药物的用途
|
|
US7456219B2
(en)
|
2002-03-04 |
2008-11-25 |
Merck Hdac Research, Llc |
Polymorphs of suberoylanilide hydroxamic acid
|
|
US20070060614A1
(en)
*
|
2002-03-04 |
2007-03-15 |
Bacopoulos Nicholas G |
Methods of treating cancer with hdac inhibitors
|
|
US20060276547A1
(en)
*
|
2002-03-04 |
2006-12-07 |
Bacopoulos Nicholas G |
Methods of treating cancer with HDAC inhibitors
|
|
WO2003075856A2
(en)
|
2002-03-07 |
2003-09-18 |
University Of Delaware |
Methods, compositions, and kits for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising a histone deacetylase inhibitor, lambda phage beta protein, or hydroxyurea
|
|
AU2003226408B2
(en)
*
|
2002-04-15 |
2007-06-14 |
Sloan-Kettering Institute For Cancer Research |
Combination therapy for the treatment of cancer
|
|
EP1511477A4
(en)
*
|
2002-05-22 |
2008-04-09 |
Errant Gene Therapeutics Llc |
HISTONE DEACETYLASE INHIBITORS BASED ON ALPHA-KETO-EPOXYDE COMPOUNDS
|
|
TW559390U
(en)
*
|
2002-08-27 |
2003-10-21 |
Molex Inc |
Electrical connector
|
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
US7250514B1
(en)
|
2002-10-21 |
2007-07-31 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
JP2006512318A
(ja)
*
|
2002-11-12 |
2006-04-13 |
アルコン，インコーポレイテッド |
眼の血管新生もしくは水腫状の疾患および障害を処置するためのヒストンデアセチラーゼインヒビター
|
|
US7244751B2
(en)
|
2003-02-14 |
2007-07-17 |
Shenzhen Chipscreen Biosciences Ltd. |
Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
|
|
US7381825B2
(en)
|
2003-03-17 |
2008-06-03 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
WO2004089293A2
(en)
|
2003-04-01 |
2004-10-21 |
Memorial Sloan-Kettering Cancer Center |
Hydroxamic acid compounds and methods of use thereof
|
|
MXPA05012464A
(es)
*
|
2003-05-21 |
2006-01-30 |
Novartis Ag |
Combinacion de inhibidores de deacetilasa de histona con agentes quimioterapeuticos.
|
|
WO2005007091A2
(en)
*
|
2003-07-07 |
2005-01-27 |
Georgetown University |
Histone deacetylase inhibitors and methods of use thereof
|
|
US7842835B2
(en)
*
|
2003-07-07 |
2010-11-30 |
Georgetown University |
Histone deacetylase inhibitors and methods of use thereof
|
|
SI1663194T1
(sl)
|
2003-08-26 |
2010-08-31 |
Merck Hdac Res Llc |
Uporaba SAHA za zdravljenje mezotelioma
|
|
CN102349927A
(zh)
*
|
2003-08-29 |
2012-02-15 |
Hdac默克研究有限责任公司 |
联合治疗癌症的方法
|
|
EP1677731A4
(en)
*
|
2003-10-09 |
2009-05-06 |
Aton Pharma Inc |
THIOPHENE AND BENZOTHIOPHENE DERIVATIVES OF HYDROXAMIC ACID
|
|
WO2005053609A2
(en)
*
|
2003-11-26 |
2005-06-16 |
Guilford Pharmaceuticals Inc. |
Methods of nad+-dependent deacetylase inhibitors
|
|
US20090023718A1
(en)
*
|
2003-11-26 |
2009-01-22 |
Aton Pharma, Inc. |
Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives
|
|
WO2005051901A1
(en)
*
|
2003-11-28 |
2005-06-09 |
The University Of Queensland |
Anti-cancer agents
|
|
WO2005059167A1
(en)
*
|
2003-12-18 |
2005-06-30 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Method for identifying histone deacetylase inhibitors
|
|
US20050159470A1
(en)
*
|
2003-12-19 |
2005-07-21 |
Syrrx, Inc. |
Histone deacetylase inhibitors
|
|
US20050137234A1
(en)
*
|
2003-12-19 |
2005-06-23 |
Syrrx, Inc. |
Histone deacetylase inhibitors
|
|
WO2005070020A2
(en)
*
|
2004-01-23 |
2005-08-04 |
The Regents Of The University Of Colorado |
Gefitinib sensitivity-related gene expression and products and methods related thereto
|
|
US20080113874A1
(en)
*
|
2004-01-23 |
2008-05-15 |
The Regents Of The University Of Colorado |
Gefitinib sensitivity-related gene expression and products and methods related thereto
|
|
CN101010298A
(zh)
*
|
2004-04-05 |
2007-08-01 |
默克Hdac研究有限责任公司 |
组蛋白脱乙酰酶抑制剂前药
|
|
ES2537631T3
(es)
*
|
2004-05-27 |
2015-06-10 |
The Regents Of The University Of Colorado |
Métodos para la predicción del resultado clínico para inhibidores del receptor del factor de crecimiento epidérmico para pacientes de cáncer
|
|
US20080262035A1
(en)
*
|
2004-07-12 |
2008-10-23 |
Chakravarty Prasun K |
Amide Derivatives as Inhibitors of Histone Deacetylase
|
|
AU2005271843A1
(en)
*
|
2004-07-12 |
2006-02-16 |
Merck Sharp & Dohme Corp. |
Histone deacetylase inhibitors
|
|
AU2005261487A1
(en)
*
|
2004-07-12 |
2006-01-19 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Amide derivatives as inhibitors of histone deacetylase
|
|
US7534918B2
(en)
*
|
2004-07-12 |
2009-05-19 |
Merck & Co., Inc. |
Histone deacetylase inhibitors
|
|
JP2008506776A
(ja)
*
|
2004-07-19 |
2008-03-06 |
メルク エンド カムパニー インコーポレーテッド |
ヒストン脱アセチル化酵素阻害剤
|
|
MX2007001550A
(es)
*
|
2004-08-09 |
2007-04-10 |
Astellas Pharma Inc |
Compuestos de hidroxiamida que tienen actividad como inhibidores de histona desacetilasa (hdac).
|
|
WO2006026260A1
(en)
*
|
2004-08-25 |
2006-03-09 |
Merck & Co., Inc. |
Histone deacetylase inhibitors
|
|
KR100584811B1
(ko)
|
2004-10-21 |
2006-05-30 |
한국화학연구원 |
히스톤 디아세틸라제 저해활성을 갖는ｎ,ｎ-다이메틸아미노페닐 옥타노산 하이드록시아마이드유도체 및 이의 제조방법
|
|
US20070021612A1
(en)
*
|
2004-11-04 |
2007-01-25 |
University Of Notre Dame Du Lac |
Processes and compounds for preparing histone deacetylase inhibitors and intermediates thereof
|
|
US7235688B1
(en)
|
2004-11-04 |
2007-06-26 |
University Of Notre Dame Du Lac |
Process for preparing histone deacetylase inhibitors and intermediates thereof
|
|
US20060160902A1
(en)
*
|
2004-11-08 |
2006-07-20 |
Wiech Norbert L |
Histone deacetylase inhibitors
|
|
EP1824831A2
(en)
*
|
2004-12-16 |
2007-08-29 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
WO2006094068A2
(en)
|
2005-03-01 |
2006-09-08 |
The Regents Of The University Of Michigan |
Hdac inhibitors that promote brm expression and brm related diagnostics
|
|
KR20080003334A
(ko)
*
|
2005-03-11 |
2008-01-07 |
더 리젠트스 오브 더 유니버시티 오브 콜로라도 |
암 세포를 표피 성장 인자 억제제에 대해 감작화시키는히스톤 데아세틸라제 억제제
|
|
WO2006113606A2
(en)
*
|
2005-04-18 |
2006-10-26 |
Johns Hopkins University |
Histone deacetylase inhibitors
|
|
EP1874294A4
(en)
|
2005-04-20 |
2010-12-01 |
Merck Sharp & Dohme |
BENZOTHIOPHENO HYDROXAMIDIC DERIVATIVES WITH CARBAMATE, UREA, AMID AND SULPHONAMIDE SUBSTITUTIONS
|
|
CN101163690A
(zh)
*
|
2005-04-20 |
2008-04-16 |
默克公司 |
苯并噻吩异羟肟酸衍生物
|
|
CA2605110A1
(en)
*
|
2005-04-20 |
2006-11-02 |
Merck & Co., Inc. |
Benzothiophene derivatives
|
|
GB0509225D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Inhibitors of enzymatic activity
|
|
GB0509226D0
(en)
*
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Enzyme and receptor modulation
|
|
GB0509223D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
|
AU2006243000B2
(en)
*
|
2005-05-05 |
2011-05-26 |
Macrophage Pharma Limited |
Alpha aminoacid ester-drug conjugates hydrolysable by carboxylesterase
|
|
EP1896436A2
(en)
*
|
2005-05-11 |
2008-03-12 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
|
TWI415603B
(zh)
*
|
2005-05-20 |
2013-11-21 |
Merck Sharp & Dohme |
１，８－辛二醯基苯胺羥胺酸（ｓｕｂｅｒｏｙｌａｎｉｌｉｄｅ ｈｙｄｒｏｘａｍｉｃ ａｃｉｄ）之調配物及其製配方法
|
|
CA2612420A1
(en)
*
|
2005-06-24 |
2007-01-04 |
Merck & Co., Inc. |
Modified malonate derivatives
|
|
EA200800321A1
(ru)
*
|
2005-07-14 |
2008-06-30 |
Такеда Сан Диего, Инк. |
Ингибиторы гистондеацетилазы
|
|
GB0518237D0
(en)
*
|
2005-09-07 |
2005-10-19 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
|
KR100696139B1
(ko)
*
|
2005-11-01 |
2007-03-20 |
한국화학연구원 |
히스톤 디아세틸라제 저해활성을 갖는 알킬카바모일나프탈렌일옥시 옥테노일 하이드록시아마이드 유도체 및그의 제조방법
|
|
WO2007055942A2
(en)
*
|
2005-11-03 |
2007-05-18 |
Merck & Co., Inc. |
Substituted nicotinamide compounds
|
|
WO2007055941A2
(en)
|
2005-11-03 |
2007-05-18 |
Merck & Co., Inc. |
Histone deacetylase inhibitors with aryl-pyrazolyl motifs
|
|
CA2627129A1
(en)
*
|
2005-11-04 |
2007-05-18 |
Merck & Co., Inc. |
Methods of using saha and bortezomib for treating cancer
|
|
US20070197568A1
(en)
*
|
2005-11-04 |
2007-08-23 |
Paul Bunn |
Methods of using SAHA and Erlotinib for treating cancer
|
|
WO2007058927A1
(en)
|
2005-11-11 |
2007-05-24 |
The Scripps Research Institute |
Histone deacetylase inhibitors as therapeutics for neurological diseases
|
|
AR057579A1
(es)
|
2005-11-23 |
2007-12-05 |
Merck & Co Inc |
Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
|
|
DK1975158T3
(da)
*
|
2005-12-27 |
2011-10-24 |
Ct Nac Investigaciones Oncologicas Cnio |
Hidtil ukendte pyrrolderivater med histondeacetylase-inhibitoraktivitet
|
|
CA2635209A1
(en)
*
|
2006-01-12 |
2007-08-02 |
Merck & Co., Inc. |
Fluorinated arylamide derivatives
|
|
AU2007208495A1
(en)
*
|
2006-01-12 |
2007-08-02 |
Merck Sharp & Dohme Corp. |
Hydroxyalkylarylamide derivatives
|
|
JP2009525955A
(ja)
*
|
2006-01-13 |
2009-07-16 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
|
CA2641579A1
(en)
*
|
2006-02-07 |
2007-08-16 |
Astellas Pharma Inc. |
N-hydroxyacrylamide compounds
|
|
WO2007095584A2
(en)
|
2006-02-14 |
2007-08-23 |
The President And Fellows Of Harvard College |
Histone Deacetylase Inhibitors
|
|
GB0603041D0
(en)
*
|
2006-02-15 |
2006-03-29 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
|
WO2007100657A2
(en)
*
|
2006-02-28 |
2007-09-07 |
Merck & Co., Inc. |
Inhibitors of histone deacetylase
|
|
WO2007113644A2
(en)
*
|
2006-04-05 |
2007-10-11 |
Orchid Research Laboratories Limited |
New hdac inhibitors
|
|
EP2012801A4
(en)
*
|
2006-04-24 |
2009-08-05 |
Gloucester Pharmaceuticals Inc |
GEMCITABINE COMBINATION THERAPY
|
|
CA2649861A1
(en)
*
|
2006-04-26 |
2007-11-08 |
Merck & Co., Inc. |
Disubstituted aniline compounds
|
|
EP2023924B1
(en)
*
|
2006-05-18 |
2016-08-03 |
Merck Sharp & Dohme Corp. |
Aryl-fused spirocyclic compounds
|
|
US8957027B2
(en)
*
|
2006-06-08 |
2015-02-17 |
Celgene Corporation |
Deacetylase inhibitor therapy
|
|
EP2049124A4
(en)
*
|
2006-07-20 |
2010-02-10 |
Merck & Co Inc |
PHOSPHOR DERIVATIVES AS HISTONDEACETYLASE HEMMER
|
|
EP2056808A4
(en)
*
|
2006-08-28 |
2009-12-23 |
Univ California |
Small molecule potentiator of hormonal therapy for breast cancer
|
|
WO2008033466A2
(en)
*
|
2006-09-14 |
2008-03-20 |
Combinatorx (Singapore) Pre. Ltd. |
Compositions and methods for treatment of viral diseases
|
|
MX2009003405A
(es)
|
2006-09-28 |
2009-04-09 |
Merck & Co Inc |
Composiciones farmaceuticas de inhibidores de la histona desacetilasa y compuestos quelantes de metal, y complejos de quelato de metal-inhibidor de histona desacetilasa.
|
|
GB0619753D0
(en)
|
2006-10-06 |
2006-11-15 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
|
GB0620823D0
(en)
*
|
2006-10-19 |
2006-11-29 |
Univ London |
Histone deacetylase inhibitors
|
|
WO2008053131A1
(en)
|
2006-10-30 |
2008-05-08 |
Chroma Therapeutics Ltd. |
Hydroxamates as inhibitors of histone deacetylase
|
|
CN101528037A
(zh)
*
|
2006-11-03 |
2009-09-09 |
默克公司 |
使用saha和硼替佐米治疗多发性骨髓瘤的方法
|
|
AU2007342028B2
(en)
|
2006-12-29 |
2013-06-13 |
Celgene Corporation |
Purifiction of romidepsin
|
|
CA2676422C
(en)
|
2007-02-06 |
2018-10-16 |
Lixte Biotechnology Holdings, Inc. |
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
|
|
US20100324034A1
(en)
*
|
2007-02-08 |
2010-12-23 |
Hazuda Daria J |
Methods of Using SAHA for Treating HIV Infection
|
|
GB2445630B
(en)
*
|
2007-03-12 |
2008-11-12 |
Cvon Innovations Ltd |
Dynamic message allocation system and method
|
|
MX2009009374A
(es)
*
|
2007-03-13 |
2009-09-21 |
Sigma Tau Ind Farmaceuti |
Compuestos de amida y su uso como agentes antitumorales.
|
|
US20080288310A1
(en)
*
|
2007-05-16 |
2008-11-20 |
Cvon Innovation Services Oy |
Methodologies and systems for mobile marketing and advertising
|
|
GB2454118B
(en)
|
2007-06-06 |
2010-06-02 |
Univ Maryland |
Hdac inhibitors and hormone targeted drugs for the treatment of cancer
|
|
AU2008269154B2
(en)
|
2007-06-27 |
2014-06-12 |
Merck Sharp & Dohme Llc |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
|
EP2170339B1
(en)
*
|
2007-06-27 |
2014-10-15 |
Merck Sharp & Dohme Corp. |
Pyridyl and pyrimidinyl derivatives as histone deacetylase inhibitors
|
|
EA018618B1
(ru)
*
|
2007-10-01 |
2013-09-30 |
Ликсте Байотекнолоджи, Инк. |
Ингибиторы hdac
|
|
WO2009067543A2
(en)
*
|
2007-11-19 |
2009-05-28 |
The Regents Of The University Of Colorado |
Treatment of histone deacetylase mediated disorders
|
|
US20110044952A1
(en)
*
|
2007-11-27 |
2011-02-24 |
Ottawa Health Research Institute |
Amplification of cancer-specific oncolytic viral infection by histone deacetylase inhibitors
|
|
EP2231596A4
(en)
*
|
2007-12-14 |
2012-06-06 |
Univ Georgetown |
INHIBITORS OF HISTONATE ACETYLASE
|
|
US7863315B2
(en)
|
2008-01-15 |
2011-01-04 |
Shenzhen Chipscreen Biosciences, Ltd. |
2-indolinone derivatives as selective histone deacetylase inhibitors
|
|
US8158656B2
(en)
|
2008-05-16 |
2012-04-17 |
Shenzhen Chipscreen Biosciences Ltd. |
2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
|
|
US8178577B2
(en)
|
2008-05-21 |
2012-05-15 |
Shenzhen Chipscreen Biosciences Ltd. |
Tricyclic derivatives as potent and selective histone deacetylase inhibitors
|
|
CA2730148C
(en)
|
2008-08-01 |
2018-04-03 |
Lixte Biotechnology, Inc. |
Neuroprotective agents for the prevention and treatment of neurodegenerative diseases
|
|
US8227473B2
(en)
|
2008-08-01 |
2012-07-24 |
Lixte Biotechnology, Inc. |
Oxabicycloheptanes and oxabicycloheptenes, their preparation and use
|
|
US10354229B2
(en)
*
|
2008-08-04 |
2019-07-16 |
Mcafee, Llc |
Method and system for centralized contact management
|
|
WO2010028193A1
(en)
*
|
2008-09-03 |
2010-03-11 |
Repligen Corporation |
Compounds including pimelic acid derivatives as hdac inhibitors
|
|
GB0903480D0
(en)
|
2009-02-27 |
2009-04-08 |
Chroma Therapeutics Ltd |
Enzyme Inhibitors
|
|
US8211901B2
(en)
|
2009-05-22 |
2012-07-03 |
Shenzhen Chipscreen Biosciences Ltd. |
Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
|
|
CN101906076B
(zh)
|
2009-06-04 |
2013-03-13 |
深圳微芯生物科技有限责任公司 |
作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用
|
|
CN102020588B
(zh)
*
|
2009-09-16 |
2014-01-29 |
深圳微芯生物科技有限责任公司 |
具有组蛋白去乙酰化酶抑制活性的三环化合物、其制备方法及应用
|
|
WO2011132712A1
(ja)
|
2010-04-20 |
2011-10-27 |
大正製薬株式会社 |
新規なヒドロキサム酸誘導体
|
|
EP2571352A4
(en)
*
|
2010-05-21 |
2014-09-17 |
Sloan Kettering Inst Cancer |
SELECTIVE HDAC HEMMER
|
|
NZ605526A
(en)
|
2010-07-12 |
2015-04-24 |
Celgene Corp |
Romidepsin solid forms and uses thereof
|
|
CN101894348B
(zh)
*
|
2010-07-20 |
2014-04-09 |
中兴通讯股份有限公司 |
一种自扩展的联机交易系统及其实现方法
|
|
US8859502B2
(en)
|
2010-09-13 |
2014-10-14 |
Celgene Corporation |
Therapy for MLL-rearranged leukemia
|
|
CN102775368B
(zh)
*
|
2011-05-10 |
2016-08-17 |
上海驺虞医药科技有限公司 |
一类噻唑类化合物及其制备方法和用途
|
|
US8921533B2
(en)
|
2011-07-25 |
2014-12-30 |
Chromatin Technologies |
Glycosylated valproic acid analogs and uses thereof
|
|
PL2758371T3
(pl)
*
|
2011-09-19 |
2017-01-31 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Nowe tiopochodne niosące laktamy jako silne inhibitory hdac i ich zastosowania jako leki
|
|
CA2850757A1
(en)
*
|
2011-10-03 |
2013-04-11 |
The Trustees Of Columbia University In The City Of New York |
Novel molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1
|
|
US9044408B2
(en)
*
|
2011-10-31 |
2015-06-02 |
Avon Products, Inc. |
Cosmetic use of N-heteroarylbisamide analogs and related compounds
|
|
JP6112733B2
(ja)
|
2012-04-06 |
2017-04-12 |
国立大学法人京都大学 |
エリスロポエチン産生細胞の誘導方法
|
|
AU2013202506B2
(en)
|
2012-09-07 |
2015-06-18 |
Celgene Corporation |
Resistance biomarkers for hdac inhibitors
|
|
AU2013202507B9
(en)
|
2012-11-14 |
2015-08-13 |
Celgene Corporation |
Inhibition of drug resistant cancer cells
|
|
EP2983661B1
(en)
|
2013-04-09 |
2024-05-29 |
Lixte Biotechnology, Inc. |
Formulations of oxabicycloheptanes and oxabicycloheptenes
|
|
CA2933907A1
(en)
|
2013-12-23 |
2015-07-02 |
The Trustees Of Columbia University In The City Of New York |
Selective hdac6 inhibitors
|
|
NZ630311A
(en)
|
2013-12-27 |
2016-03-31 |
Celgene Corp |
Romidepsin formulations and uses thereof
|
|
WO2015184260A2
(en)
|
2014-05-30 |
2015-12-03 |
The Johns Hopkins University |
Methods for treating mendelian disorders of the epigenetic machinery
|
|
EP3328185B1
(en)
|
2015-07-28 |
2020-06-24 |
Vilmorin & Cie |
Method for producing haploid, dihaploid and doubled haploid plants by isolated microspore culture
|
|
TWI808055B
(zh)
|
2016-05-11 |
2023-07-11 |
美商滬亞生物國際有限公司 |
Hdac 抑制劑與 pd-1 抑制劑之組合治療
|
|
TWI794171B
(zh)
|
2016-05-11 |
2023-03-01 |
美商滬亞生物國際有限公司 |
Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療
|
|
MX2019006694A
(es)
|
2016-12-08 |
2019-08-21 |
Lixte Biotechnology Inc |
Oxabicicloheptanos para la modulacion de la respuesta inmunitaria.
|
|
WO2019036607A1
(en)
*
|
2017-08-17 |
2019-02-21 |
The University Of Toledo |
IMIDAZOLE ANTICANCER AGENTS AND DERIVATIVES THEREOF, AND METHODS OF MAKING THEM AND METHODS OF USE THEREOF
|
|
EP3461488A1
(en)
|
2017-09-27 |
2019-04-03 |
Onxeo |
Combination of a dbait molecule and a hdac inhibitor for treating cancer
|
|
EP3461480A1
(en)
|
2017-09-27 |
2019-04-03 |
Onxeo |
Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer
|
|
CN107698464A
(zh)
*
|
2017-10-12 |
2018-02-16 |
江苏师范大学 |
具有组蛋白去乙酰化酶抑制作用的贝利司他结构类似物及其应用
|
|
CN107822916A
(zh)
*
|
2017-11-14 |
2018-03-23 |
江苏师范大学 |
一种美白活性成分
|
|
US11026963B2
(en)
|
2018-07-11 |
2021-06-08 |
Rubedo Life Sciences, Inc. |
Senolytic compositions and uses thereof
|
|
WO2021148581A1
(en)
|
2020-01-22 |
2021-07-29 |
Onxeo |
Novel dbait molecule and its use
|
|
US20250134952A1
(en)
|
2021-09-20 |
2025-05-01 |
Institut National de la Santé et de la Recherche Médicale |
Methods for improving the efficacy of hdac inhibitor therapy and predicting the response to treatment with hdac inhibitor
|
|
CN119546293A
(zh)
|
2022-04-05 |
2025-02-28 |
国家癌症研究所Irccs-G·帕斯卡莱基金会 |
Hdac抑制剂和他汀类药物的组合用于治疗胰腺癌
|
|
WO2025026925A1
(en)
|
2023-07-28 |
2025-02-06 |
Ospedale San Raffaele S.R.L. |
Gtf2i inhibitors and uses thereof
|